
Testing Minimal Residual Disease in NonSecretory Myeloma Patients with clonoSEQ
Aug 23, 2022
01:00PM - 02:00PM EDT
Online Event
Meet with us this month to discuss minimal residual disease testing and how it can be beneficial to nonsecretory myeloma patient care.
Agenda
01:00 PM
Introduction
Vicki Jones
Vicki introduces the agenda of the event and featured speaker Mark Schliekelman.
01:05 PM
Presentation
Mark Schliekelman
Mark discusses minimal residual disease testing for Non-Secretory patients.
01:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them!

Audrey Burton-Bethke
Audrey is a content writer and editor for the HealthTree Foundation.

Vicki Jones
I’ve been fighting Multiple Myeloma for more than 15 years.

Mark Schliekelman